Point72 Hong Kong LTD Bristol Myers Squibb CO Transaction History

Point72 Hong Kong LTD

  • $1.35 Billion
  • Q3 2024

A detailed history of Point72 Hong Kong LTD transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Point72 Hong Kong LTD holds 24,312 shares of BMY stock, worth $1.4 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
24,312
Previous 258,297 90.59%
Holding current value
$1.4 Million
Previous $10.7 Million 88.27%
% of portfolio
0.09%
Previous 0.68%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$39.66 - $51.75 $9.28 Million - $12.1 Million
-233,985 Reduced 90.59%
24,312 $1.26 Million
Q2 2024

Aug 14, 2024
BUY
$40.25 - $52.99 $10.4 Million - $13.7 Million
258,297 New
258,297 $10.7 Million
Q4 2023

Feb 14, 2024
BUY
$48.48 - $57.85 $3.98 Million - $4.74 Million
81,996 New
81,996 $4.21 Million
Q2 2022

Aug 15, 2022
BUY
$72.62 - $79.98 $133,911 - $147,483
1,844 Added 3.06%
62,143 $4.79 Million
Q1 2022

May 16, 2022
SELL
$61.48 - $73.72 $519,567 - $623,007
-8,451 Reduced 12.29%
60,299 $4.4 Million
Q4 2021

Feb 14, 2022
BUY
$53.63 - $62.52 $3.51 Million - $4.09 Million
65,402 Added 1953.46%
68,750 $4.29 Million
Q3 2021

Nov 15, 2021
BUY
$59.17 - $69.31 $163,664 - $191,711
2,766 Added 475.26%
3,348 $198,000
Q2 2021

Aug 16, 2021
SELL
$61.91 - $67.42 $3.89 Million - $4.23 Million
-62,763 Reduced 99.08%
582 $39,000
Q1 2021

May 17, 2021
SELL
$59.34 - $66.74 $3.01 Million - $3.39 Million
-50,797 Reduced 44.5%
63,345 $4 Million
Q4 2020

Feb 16, 2021
BUY
$57.74 - $65.43 $5.85 Million - $6.63 Million
101,340 Added 791.6%
114,142 $7.08 Million
Q3 2020

Nov 16, 2020
SELL
$57.43 - $63.64 $1.6 Million - $1.78 Million
-27,913 Reduced 68.56%
12,802 $772,000
Q2 2020

Aug 14, 2020
BUY
$54.82 - $64.09 $2.14 Million - $2.51 Million
39,086 Added 2399.39%
40,715 $2.39 Million
Q1 2020

May 15, 2020
SELL
$46.4 - $67.43 $6,217 - $9,035
-134 Reduced 7.6%
1,629 $91,000
Q4 2019

Feb 14, 2020
BUY
$49.21 - $64.19 $86,757 - $113,166
1,763 New
1,763 $113,000
Q3 2019

Nov 14, 2019
SELL
$42.77 - $50.71 $122,749 - $145,537
-2,870 Closed
0 $0
Q2 2019

Aug 14, 2019
SELL
$44.62 - $49.34 $524,641 - $580,139
-11,758 Reduced 80.38%
2,870 $130,000
Q1 2019

May 15, 2019
BUY
$45.12 - $53.8 $660,015 - $786,986
14,628 New
14,628 $698,000
Q2 2018

Aug 14, 2018
SELL
$50.53 - $62.98 $60,029 - $74,820
-1,188 Closed
0 $0
Q1 2018

May 15, 2018
SELL
$59.92 - $68.98 $11,324 - $13,037
-189 Reduced 13.73%
1,188 $75,000
Q4 2017

Feb 14, 2018
BUY
$59.94 - $65.35 $82,537 - $89,986
1,377
1,377 $84,000

Others Institutions Holding BMY

# of Institutions
2,536
Shares Held
1.47B
Call Options Held
31.6M
Put Options Held
35M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Point72 Hong Kong LTD Portfolio

Follow Point72 Hong Kong LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Hong Kong LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email